Warsaw 2013 Programme Registration Exhibition Hotels Virtual Exhibition Warsaw Satellite Meetings Visa Information

Evaluation of quality of life after phacoemulsification with implantation of an accommodating intraocular lens

Poster Details

First Author: M.Wilczynski POLAND

Co Author(s):    M. Lugowska   M. Starus   A. Synder   W. Omulecki     

Abstract Details



Purpose:

The purpose of our study was to evaluate the quality of life of patients after cataract surgery with the implantation of an accommodating intraocular lens and to compare the results with the data from patients after cataract surgery with the implantation of a standard monofocal intraocular lens.

Setting:

: Department of Ophthalmology, Medical University of Lodz, Poland.

Methods:

The examined group (Group I) consisted of 20 patients (40 eyes), including 12 women (60%) and 8 men (40%), aged from 48 to 73 years old (mean age 63 years, standard deviation 6.6), who underwent phacoemulsification through a 2.75mm clear corneal incision. All surgeries in this group were performed using Stellaris (Bausch&Lomb) and Infiniti (Alcon) phaco machines with a 'burst' option. In all patients from group I an accommodating intraocular lens Crystalens HD was implanted. The reference group (Group II) consisted of 20 patients (40 eyes), including 15 women (75%) and 5 men (25%), aged from 63 to 83 years old (mean age 74 years, standard deviation 6.2), ), who underwent phacoemulsification through a 2.75mm clear corneal incision. All surgeries in this group were performed using Stellaris (Bausch&Lomb) and Infiniti (Alcon) phaco machines with a 'burst' option. In all patients from group II a standard monofocal single-piece acrylic intraocular lens was implanted. In all patients there were no coexisting ocular diseases which could influence the final visual acuity. All surgeries were uneventful. Patients participating in the survey answered after at least one month from the surgery to 36 questions included in the questionnaire evaluating the quality of visual function.

Results:

It was found that after cataract surgery there was a significant improvement in the quality of life in both examined groups.The esteem of patients' own eyesight after phacoemulsification with an implantation of an accommodating intraocular lens was much higher than in the group with a standard monofocal intraocular lens. Patients after phacoemulsification with an accommodating intraocular lens use spectacle correction for a smaller number of activities, they have less trouble with performing precise activities without spectacle correction (e.g. threading a needle, fitting a screw etc.) in comparison with patients with a standard monofocal intraocular lens. Patients with an accommodating intraocular lens use spectacle correction for reading significantly less frequently, they also have less trouble with reading normal and small print without spectacle correction, in comparison with patients with a standard monofocal intraocular lens. In both groups, problems with performing precise activities (e.g. threading a needle, fitting a screw etc.) with spectacle correction for near are similar and small, moreover, patients have no problems with personal hygiene (e.g. shaving, setting hair or make-up).

Conclusions:

1. There was a significant increase in the quality of life of patients from both groups. 2. Patients after phacoemulsification with an implantation of an accommodating intraocular lens have a higher esteem of their own eyesight than patients with a standard monofocal intraocular lens. 3. Patients after phacoemulsification with an implantation of an accommodating intraocular lens use spectacle correction for a smaller number of activities than patients with a standard monofocal intraocular lens. 4. Patients after phacoemulsification with an implantation of an accommodating intraocular lens have significantly less trouble with performing precise activities, as well as with reading normal and small print without spectacle correction, in comparison with patients with a standard monofocal intraocular lens.

Financial Disclosure:

None

Back to previous